Inventor · disambiguated record
David Michael Goldstein
Also filed as: GOLDSTEIN DAVID · GOLDSTEIN DAVID M · GOLDSTEIN DAVID MICHAEL
59 granted patents·16 pending applications·623 citations·filing 1992–2024
99Inventor score
Files withPRINCIPIA BIOPHARMA INC22ROCHE PALO ALTO LLC19SYNTEX LLC16GOLDSTEIN DAVID MICHAEL3ARZENO HUMBERTO BARTOLOME2
Top patents by PatentIndex Score
75 records- 0199US8673925B1Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Mar 18, 2014·114 cites·22 claims
- 0298US9090621B2Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2014·Granted Jul 28, 2015·29 cites·8 claims
- 0398US8759358B1Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Jun 24, 2014·22 cites·16 claims
- 0497US8962635B2Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2014·Granted Feb 24, 2015·17 cites·1 claims
- 0597US8957080B2Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Feb 17, 2015·19 cites·24 claims
- 0697US8946241B2Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2014·Granted Feb 3, 2015·18 cites·8 claims
- 0796US11827656B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2021·Granted Nov 28, 2023·2 cites·27 claims
- 0893US11225493B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2018·Granted Jan 18, 2022·4 cites·32 claims
- 0992US8962831B2Tyrosine kinase inhibitorsGOLDSTEIN DAVID MICHAEL·Filed 2012·Granted Feb 24, 2015·19 cites·2 claims
- 1091US6479507B2p38 MAP kinase inhibitorsSYNTEX LLC·Filed 2001·Granted Nov 12, 2002·37 cites·12 claims
- 1188US9376438B2Pyrazolopyrimidine derivatives as tyrosine kinase inhibitorsGOLDSTEIN DAVID MICHAEL·Filed 2012·Granted Jun 28, 2016·14 cites·20 claims
- 1288US7456185B2Substituted quinazoline compounds useful as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2007·Granted Nov 25, 2008·10 cites·12 claims
- 1388US6696566B26-substituted pyrido-pyrimidinesSYNTEX LLC·Filed 2002·Granted Feb 24, 2004·27 cites·55 claims
- 1488US6518276B27-oxo-pyridopyrimidines (II)SYNTEX LLC·Filed 2001·Granted Feb 11, 2003·27 cites·13 claims
- 1587US7435731B2Substituted pyrazolo[3,4-d]pyrimadines and methods of using the sameROCHE PALO ALTO LLC·Filed 2005·Granted Oct 14, 2008·11 cites·16 claims
- 1687US6451804B1Heteroalkylamino-substituted bicyclic nitrogen heterocyclesSYNTEX LLC·Filed 2000·Granted Sep 17, 2002·35 cites·31 claims
- 1786US7495015B2Indazole derivatives and methods for using the sameROCHE PALO ALTO LLC·Filed 2005·Granted Feb 24, 2009·10 cites·8 claims
- 1886US2025197402A1Tyrosine Kinase InhibitorsPRINCIPIA BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 1985US11154563B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2018·Granted Oct 26, 2021·2 cites·28 claims
- 2085US7452880B2Substituted pyrazolo [3,4-d] pyrimidines and methods of using the sameARORA NIDHI·Filed 2005·Granted Nov 18, 2008·15 cites·12 claims
- 2184US7501410B2Methods of inhibiting BTK and SYK protein kinasesROCHE PALO ALTO LLC·Filed 2007·Granted Mar 10, 2009·7 cites·1 claims
- 2283US6506749B27-oxo-pyridopyrimidines (I)SYNTEX LLC·Filed 2001·Granted Jan 14, 2003·17 cites·29 claims
- 2383US6444696B1Pyrazole derivatives P38 MAP kinase inhibitorsSYNTEX LLC·Filed 2001·Granted Sep 3, 2002·17 cites·29 claims
- 2481US2023151012A1Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2022·Application pending·0 cites
- 2580US7238698B2Substituted quinazoline compounds useful as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Jul 3, 2007·12 cites·18 claims
- 2679US6861423B2Methods of treating p38 kinase-mediated disorders with pyrido[2,3-d]pyrimidin-7-one compoundsSYNTEX LLC·Filed 2002·Granted Mar 1, 2005·11 cites·24 claims
- 2778US12312370B2Immunoproteasome inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2023·Granted May 27, 2025·0 cites·20 claims
- 2878US8268840B2Pyrimidinyl pyridone inhibitors of kinasesBROOKFIELD FREDERICK·Filed 2009·Granted Sep 18, 2012·8 cites·8 claims
- 2978US6753427B27-oxo-pyridopyrimidines (II)SYNTEX LLC·Filed 2002·Granted Jun 22, 2004·9 cites·4 claims
- 3075US7449581B26-Substituted pyrido-pyrimidinesPOCHE PALO ALTO LLC·Filed 2007·Granted Nov 11, 2008·3 cites·1 claims
- 3175US7285561B2Imidazo-substituted compounds as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Oct 23, 2007·1 cites·10 claims
- 3275US7081462B2Imidazo-substituted compounds as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2005·Granted Jul 25, 2006·1 cites·11 claims
- 3375US6630485B2p38 map kinase inhibitorsSYNTEX LLC·Filed 2001·Granted Oct 7, 2003·6 cites·21 claims
- 3474US7320987B26-Alkoxy-pyrido-pyrimidinesROCHE PALO ALTO LLC·Filed 2007·Granted Jan 22, 2008·1 cites·9 claims
- 3574US6316464B1P38 MAP kinase inhibitorsSYNTEX LLC·Filed 1998·Granted Nov 13, 2001·26 cites·21 claims
- 3673US6642241B1Alkylamino-substituted bicyclic nitrogen heterocyclesSYNTEX LLC·Filed 2000·Granted Nov 4, 2003·9 cites·22 claims
- 3771US8399462B2JNK modulatorsDUNN JAMES PATRICK·Filed 2007·Granted Mar 19, 2013·2 cites·19 claims
- 3871US6949560B2Imidazo-substituted compounds as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2003·Granted Sep 27, 2005·3 cites·21 claims
- 3971US2021171526A1Tyrosine Kinase InhibitorsPRINCIPIA BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 4070US8183254B2Inhibitors of JNKARZENO HUMBERTO BARTOLOME·Filed 2009·Granted May 22, 2012·2 cites·22 claims
- 4169US6376527B1Pyrazole derivatives-p38 map kinase inhibitorsSYNTEX LLC·Filed 1999·Granted Apr 23, 2002·13 cites·23 claims
- 4268US9676778B2Substituted pyrrolo[2,3-b]pyrazines as JAK3 inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2013·Granted Jun 13, 2017·1 cites·24 claims
- 4368US6696471B2Aminopyrrole compoundsSYNTEX LLC·Filed 2002·Granted Feb 24, 2004·3 cites·18 claims
- 4467US5530141A2,4-diaryl-1,3-dithiolanes; 2,4-diaryl-1,3-dioxolanes; 2,4-diaryl-1,3-oxathiolanes; and 2,5-diaryl-1,3-oxathiolanes for the treatment of disorders mediated by platelet activating factor or products of 5-lipoxygenaseINNOVATIVE TECH CENTER·Filed 1992·Granted Jun 25, 1996·11 cites·29 claims
- 4565US2015353562A1Tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2015·Application pending·0 cites
- 4664US11155544B2Heterocycle comprising tyrosine kinase inhibitorsPRINCIPIA BIOPHARMA INC·Filed 2019·Granted Oct 26, 2021·0 cites·4 claims
- 4764US7189731B2Substituted 7-azaquinazoline compounds useful as p38 kinase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Mar 13, 2007·1 cites·19 claims
- 4864US6965030B26-alkoxy-pyrido-pyridineROCHE PALO ALTO LLC·Filed 2003·Granted Nov 15, 2005·1 cites·9 claims
- 4962US8163906B2Dihydroquinone and dihydronaphthridine inhibitors of JNKABBOT SARAH C·Filed 2008·Granted Apr 24, 2012·1 cites·14 claims
- 5062US7750016B2Hydroxyalkyl substituted pyrido-7-pyrimidin-7-onesROCHE PALO ALTO LLC·Filed 2007·Granted Jul 6, 2010·0 cites·17 claims
Showing the top 50 of 75 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when David Michael Goldstein files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →